Newsletter | June 18, 2025

06.18.25 -- U.S. Tariffs And Their Tenuous Impact On Clinical Trials

SPONSOR

Master protocols accelerate clinical research

Partnering with the right CRO for adaptive design and operational execution can reduce duplication and improve efficiency. Read the white paper.

DECENTRALIZED TRIALS

U.S. Tariffs And Their Tenuous Impact On Clinical Trials

RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and they're anticipated impact on the pharma world, specifically clinical research.

A Smartphone Based Biomarker For Mood Disorders

The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.

Move The Needle On Clinical Research

Adaptable to any trial study, this team of experienced Certified Mobile Research Nurses travels directly to your trial participants, wherever they may be — at home, work, school, care centers, and more.

TRIAL MANAGEMENT

Evolving Neurology And Neuroinflammation Therapies And Trials In 2025

Could 2025 be the year that advancements in brain health and increased funding for innovative therapies make a difference for neuroinflammation therapies and trials? Immunic CEO Daniel Vitt, Ph.D., discusses.

Achieving Harmonious And Optimized Site Budget Negotiations

Review findings from research efforts into how principal investigators survive the complex process, identify coping strategies, and combat budget negotiation challenges.

Reimagining The Protocol For The Future Of Research

Clinical trial protocols are the blueprints of research, yet they remain locked in static, text-based documents that must be manually reinterpreted across each clinical system.

A Strategic Guide For Biotech And Biopharma Leaders

Securing drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.

The Benefits Of US Biotechs Conducting Clinical Trials In Australia

As U.S. biotech investment continues to rise, cross-border collaboration and trial design innovations are expected to further solidify Australia’s role in the early-stage biotech development pipeline.

Precision Medicine In Pediatrics: Biomarkers And Assay Development

Discover the rise in FDA-approved pediatric therapies and the role of precision medicine in tailoring treatments to genetic profiles, as well as how biomarkers and assays can enhance pediatric care.

What Is The Role Of Large Language Models In RWE Generation?

Large language models (LLMs) are generative AI models that can analyze and curate large amounts of RWD - at an unprecedented scale and speed - to generate real-world evidence (RWE).

Why Team Integration Makes Or Breaks Marketing Applications

True team integration transcends basic collaboration, requiring the dismantling of barriers between sponsors and vendors, eliminating departmental silos, and cultivating mutual accountability.

Why Australia Is The Best Place In The World For Early Phase Studies

The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.

Connect With Clinical Leader: